Yong-rong H. Lai

Nanning, 530021, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 27 publications

Expression Changes of Hypoxia-Inducible Factor-1α in G-CSF Induced Hematopoietic Stem Cell Mobilization

Expression Changes of Hypoxia-Inducible Factor-1α in G-CSF Induced Hematopoietic Stem Cell Mobilization

Journal: Zhongguo shi yan xue ye xue za zhi
Published: February 11, 2023

Thalassaemia in China.

Thalassaemia in China.

Journal: Blood reviews
Published: September 16, 2022

Hematopoietic Stem Cell Transplantation Activity in China 2020-2021 During the SARS-CoV-2 Pandemic: A Report From the Chinese Blood and Marrow Transplantation Registry Group.

Hematopoietic Stem Cell Transplantation Activity in China 2020-2021 During the SARS-CoV-2 Pandemic: A Report From the Chinese Blood and Marrow Transplantation Registry Group.

Journal: Transplantation and cellular therapy
Published: September 05, 2022

Poor pretransplantation minimal residual disease clearance as an independent prognostic risk factor for survival in myelodysplastic syndrome with excess blasts: A multicenter, retrospective cohort study.

Poor pretransplantation minimal residual disease clearance as an independent prognostic risk factor for survival in myelodysplastic syndrome with excess blasts: A multicenter, retrospective cohort study.

Journal: Cancer
Published: August 30, 2022

An open-label, multicenter, efficacy, and safety study of deferasirox in iron-overloaded patients with non-transfusion-dependent thalassemia (THETIS): 5-year results.

An open-label, multicenter, efficacy, and safety study of deferasirox in iron-overloaded patients with non-transfusion-dependent thalassemia (THETIS): 5-year results.

Journal: American journal of hematology
Published: February 15, 2022

Clinical Analysis of Bloodstream Infection after Hematopoietic Stem Cell Transplantation

Clinical Analysis of Bloodstream Infection after Hematopoietic Stem Cell Transplantation

Journal: Zhongguo shi yan xue ye xue za zhi
Published: February 06, 2022

The consensus from The Chinese Society of Hematology on indications, conditioning regimens and donor selection for allogeneic hematopoietic stem cell transplantation: 2021 update.

The consensus from The Chinese Society of Hematology on indications, conditioning regimens and donor selection for allogeneic hematopoietic stem cell transplantation: 2021 update.

Journal: Journal of hematology & oncology
Published: July 19, 2021

Arsenic trioxide replacing or reducing chemotherapy in consolidation therapy for acute promyelocytic leukemia (APL2012 trial).

Arsenic trioxide replacing or reducing chemotherapy in consolidation therapy for acute promyelocytic leukemia (APL2012 trial).

Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: January 26, 2021

Application of Gene Therapy in Hemophilia.

Application of Gene Therapy in Hemophilia.

Journal: Current medical science
Published: January 18, 2021

Reply to M. Shibusawa et al.

Reply to M. Shibusawa et al.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: October 26, 2020

Hematopoietic stem cell transplantation activity in China 2019: a report from the Chinese Blood and Marrow Transplantation Registry Group.

Hematopoietic stem cell transplantation activity in China 2019: a report from the Chinese Blood and Marrow Transplantation Registry Group.

Journal: Bone marrow transplantation
Published: August 19, 2020

Antithymocyte Globulin for Matched Sibling Donor Transplantation in Patients With Hematologic Malignancies: A Multicenter, Open-Label, Randomized Controlled Study.

Antithymocyte Globulin for Matched Sibling Donor Transplantation in Patients With Hematologic Malignancies: A Multicenter, Open-Label, Randomized Controlled Study.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: July 12, 2020
Showing 1-12 of 27

Last Updated: 09/26/2026